Can you just stay on 2.5mg Mounjaro and skip titrating up?

What is 2.5mg actually for?

A question our prescribers hear most weeks is whether staying at 2.5mg is an option, and you can find a detailed look at exactly that on our page covering whether you can stay on 2.5mg of Mounjaro. The short answer: it is an option, but it's worth understanding what the dose is and isn't designed to do.

The 2.5mg starting dose exists to settle your system. Tirzepatide slows gastric emptying and acts on appetite-regulating pathways, and beginning at a low dose reduces the intensity of early nausea, vomiting and digestive discomfort that many people notice in the first few weeks. In that sense, 2.5mg is doing its job correctly even when you feel little change on the scales.

The NHS tirzepatide medicines page describes the titration schedule as stepping up approximately every four weeks, with the prescriber guiding the pace. The schedule exists because clinical trial data (including the SURMOUNT-1 study published in the New England Journal of Medicine) showed meaningful weight reduction at doses of 5mg and above, with the strongest results at 10mg and 15mg. At 2.5mg alone, trial participants were not observed to achieve the same outcomes. That doesn't mean 2.5mg has no effect; it means the full effect comes at higher doses for most people.

If you're curious how the 5mg step compares in practice, the 5mg Mounjaro page covers what that dose typically involves.

Are there legitimate reasons to stay at 2.5mg for longer?

There are. Side effects are the most common one. If nausea, vomiting or diarrhoea are significant and haven't settled after a few weeks, a prescriber may decide the right move is to hold the current dose rather than escalating. The goal is always to find the highest dose you can tolerate, not to tick a calendar.

Personal circumstances can also play a role. Some people have travel coming up, a surgery scheduled, or a period of significant stress where introducing a dose change feels unwise. These are conversations worth having openly with your clinician rather than making a unilateral call.

What's less sound is staying at 2.5mg because it feels safer, or because the idea of side effects at a higher dose is worrying. That anxiety is understandable (genuinely) but the evidence for weight-related health improvement is concentrated at maintenance doses. Holding back indefinitely tends to mean lower outcomes for the same commitment and cost.

If you're concerned that the current dose isn't producing results, the page on 2.5mg tirzepatide not working goes into this in more detail, and is worth reading before your next review.

Can you stay at 2.5mg permanently?

Technically, a prescriber could continue a prescription at 2.5mg indefinitely if they judged it clinically appropriate. In practice this is rare, and here's why.

NICE's appraisal of tirzepatide, TA1026, recommends the medicine for adults meeting BMI and comorbidity criteria, with a review after six months to assess whether at least 5% body weight has been lost. If it hasn't (at the highest tolerated dose) continuing is reviewed. A patient who never moved past 2.5mg and showed minimal progress would be unlikely to meet that continuation threshold, whether on the NHS or under private prescribing.

For those considering what longer-term dose management looks like, it's also worth knowing that different dose levels carry different clinical considerations. Patients sometimes ask about holding at 7.5mg as a middle ground; the 7.5mg Mounjaro dose page covers that question directly.

The cost dimension matters too. Mounjaro treatment carries a monthly cost whether you're at 2.5mg or 15mg, and staying at a sub-therapeutic dose for months means spending without the expected benefit. For a clear picture of what's included in private treatment pricing, the Mounjaro pricing page sets that out honestly.

What should you do if you want to stay at 2.5mg?

Tell your prescriber. That's really the whole answer.

Don't quietly stop titrating or decline a repeat prescription without an explanation, your prescriber needs to know your reasoning to give you sound clinical advice. Side effects they don't know about can't be managed. Concerns about moving up can often be addressed by slowing the titration, not abandoning it.

If you're not currently under clinical oversight, or you're thinking about starting Mounjaro and want to understand the full process before committing, the Mounjaro overview page covers eligibility, how prescribing works and what to expect. And if you have general questions about how we approach clinical review at nume, our about us page explains our pharmacy's setup and the prescribers behind it.

Every repeat order with us is reviewed by a GPhC-registered prescriber before dispatch, a real clinician reads your update, not a system that auto-approves. That structure exists precisely so that questions like this one get a proper answer, specific to you.